CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 7, Pages 1472-1477
Publisher
Springer Nature
Online
2014-01-09
DOI
10.1038/leu.2014.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calreticulin for better or for worse, in sickness and in health, until death do us part
- (2013) Paul Eggleton et al. CELL CALCIUM
- Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
- (2013) Olga Vaksman et al. HUMAN PATHOLOGY
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calreticulin Induces Dilated Cardiomyopathy
- (2013) Dukgyu Lee et al. PLoS One
- Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
- (2012) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival
- (2012) T. L. Lasho et al. BLOOD
- Calreticulin signaling in health and disease
- (2012) Wen-An Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Leukemia risk models in primary myelofibrosis: an International Working Group study
- (2012) A Tefferi et al. LEUKEMIA
- Overexpression of Calreticulin in Malignant and Benign Breast Tumors: Relationship with Humoral Immunity
- (2012) Aleksandra Erić-Nikolić et al. ONCOLOGY
- Calreticulin in the immune system: ins and outs
- (2012) Malini Raghavan et al. TRENDS IN IMMUNOLOGY
- EZH2 mutational status predicts poor survival in myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival
- (2011) R. Vaidya et al. BLOOD
- IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F
- (2011) A Tefferi et al. LEUKEMIA
- SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
- (2011) T L Lasho et al. LEUKEMIA
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
- Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients
- (2010) D Caramazza et al. LEUKEMIA
- Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
- (2010) M Wemeau et al. Cell Death & Disease
- Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum
- (2009) Marek Michalak et al. BIOCHEMICAL JOURNAL
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Calreticulin: non-endoplasmic reticulum functions in physiology and disease
- (2009) Leslie I. Gold et al. FASEB JOURNAL
- Embryonic Stem Cell-Derived Cardiomyogenesis: A Novel Role for Calreticulin as a Regulator
- (2009) Sylvia Papp et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now